| Symbol |
Name |
|
ABCC2
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 2
|
|
ABL1
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
|
ADCYAP1R1
|
adenylate cyclase activating polypeptide 1 (pituitary) receptor type I
|
|
AFF1
|
AF4/FMR2 family, member 1
|
|
AHR
|
aryl hydrocarbon receptor
|
|
AKAP9
|
A kinase (PRKA) anchor protein 9
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
AKT2
|
v-akt murine thymoma viral oncogene homolog 2
|
|
ALK
|
anaplastic lymphoma receptor tyrosine kinase
|
|
AMBRA1
|
autophagy/beclin-1 regulator 1
|
|
ANGPT2
|
angiopoietin 2
|
|
ANK1
|
ankyrin 1, erythrocytic
|
|
AP1S3
|
adaptor-related protein complex 1, sigma 3 subunit
|
|
APAF1
|
apoptotic peptidase activating factor 1
|
|
APOA1
|
apolipoprotein A-I
|
|
AQP1
|
aquaporin 1 (Colton blood group)
|
|
AQP4
|
aquaporin 4
|
|
AR
|
androgen receptor
|
|
ARID1A
|
AT rich interactive domain 1A (SWI-like)
|
|
ASCL1
|
achaete-scute family bHLH transcription factor 1
|
|
ASXL1
|
additional sex combs like transcriptional regulator 1
|
|
ATOH1
|
atonal homolog 1 (Drosophila)
|
|
ATP7B
|
ATPase, Cu++ transporting, beta polypeptide
|
|
ATR
|
ATR serine/threonine kinase
|
|
BARD1
|
BRCA1 associated RING domain 1
|
|
BAX
|
BCL2-associated X protein
|
|
BBC3
|
BCL2 binding component 3
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BCR
|
breakpoint cluster region
|
|
BDNF
|
brain-derived neurotrophic factor
|
|
BRCA1
|
breast cancer 1, early onset
|
|
BRCA2
|
breast cancer 2, early onset
|
|
C10ORF2
|
chromosome 10 open reading frame 2
|
|
C12ORF42
|
chromosome 12 open reading frame 42
|
|
CACNA1H
|
calcium channel, voltage-dependent, T type, alpha 1H subunit
|
|
CAND1
|
cullin-associated and neddylation-dissociated 1
|
|
CASP1
|
caspase 1, apoptosis-related cysteine peptidase
|
|
CCL2
|
chemokine (C-C motif) ligand 2
|
|
CCL3
|
chemokine (C-C motif) ligand 3
|
|
CCL4
|
chemokine (C-C motif) ligand 4
|
|
CCR5
|
chemokine (C-C motif) receptor 5 (gene/pseudogene)
|
|
CD40LG
|
CD40 ligand
|
|
CD81
|
CD81 molecule
|
|
CDC20
|
cell division cycle 20
|
|
CDK4
|
cyclin-dependent kinase 4
|
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
|
CDKN1B
|
cyclin-dependent kinase inhibitor 1B (p27, Kip1)
|
|
CEP152
|
centrosomal protein 152kDa
|
|
CFL2
|
cofilin 2 (muscle)
|
|
CHEK1
|
checkpoint kinase 1
|
|
CLN3
|
ceroid-lipofuscinosis, neuronal 3
|
|
CNR1
|
cannabinoid receptor 1 (brain)
|
|
CNTNAP2
|
contactin associated protein-like 2
|
|
COPA
|
coatomer protein complex, subunit alpha
|
|
CREB3L2
|
cAMP responsive element binding protein 3-like 2
|
|
CSPG4
|
chondroitin sulfate proteoglycan 4
|
|
CTCF
|
CCCTC-binding factor (zinc finger protein)
|
|
CTLA4
|
cytotoxic T-lymphocyte-associated protein 4
|
|
CTNNA3
|
catenin (cadherin-associated protein), alpha 3
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
|
CX3CL1
|
chemokine (C-X3-C motif) ligand 1
|
|
CX3CR1
|
chemokine (C-X3-C motif) receptor 1
|
|
CXCL12
|
chemokine (C-X-C motif) ligand 12
|
|
CXCL5
|
chemokine (C-X-C motif) ligand 5
|
|
CXCR4
|
chemokine (C-X-C motif) receptor 4
|
|
DBI
|
diazepam binding inhibitor (GABA receptor modulator, acyl-CoA binding protein)
|
|
DBN1
|
drebrin 1
|
|
DCTN1
|
dynactin 1
|
|
DES
|
desmin
|
|
DICER1
|
dicer 1, ribonuclease type III
|
|
DISC1
|
disrupted in schizophrenia 1
|
|
DKC1
|
dyskeratosis congenita 1, dyskerin
|
|
DMD
|
dystrophin
|
|
DPYD
|
dihydropyrimidine dehydrogenase
|
|
DROSHA
|
drosha, ribonuclease type III
|
|
DYNLT1
|
dynein, light chain, Tctex-type 1
|
|
EGF
|
epidermal growth factor
|
|
EGFR
|
epidermal growth factor receptor
|
|
ELMO1
|
engulfment and cell motility 1
|
|
EP300
|
E1A binding protein p300
|
|
EPHA3
|
EPH receptor A3
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ESR1
|
estrogen receptor 1
|
|
F2RL3
|
coagulation factor II (thrombin) receptor-like 3
|
|
FANCC
|
Fanconi anemia, complementation group C
|
|
FAS
|
Fas cell surface death receptor
|
|
FBLN1
|
fibulin 1
|
|
FBXO32
|
F-box protein 32
|
|
FBXW4
|
F-box and WD repeat domain containing 4
|
|
FEZ1
|
fasciculation and elongation protein zeta 1 (zygin I)
|
|
FHIT
|
fragile histidine triad
|
|
FIGLA
|
folliculogenesis specific basic helix-loop-helix
|
|
FOLH1
|
folate hydrolase (prostate-specific membrane antigen) 1
|
|
FOXO1
|
forkhead box O1
|
|
FOXO3
|
forkhead box O3
|
|
FOXO4
|
forkhead box O4
|
|
FOXP2
|
forkhead box P2
|
|
FRG1B
|
FSHD region gene 1 family, member B
|
|
FURIN
|
furin (paired basic amino acid cleaving enzyme)
|
|
GABRA3
|
gamma-aminobutyric acid (GABA) A receptor, alpha 3
|
|
GABRB2
|
gamma-aminobutyric acid (GABA) A receptor, beta 2
|
|
GADD45A
|
growth arrest and DNA-damage-inducible, alpha
|
|
GFM1
|
G elongation factor, mitochondrial 1
|
|
GHR
|
growth hormone receptor
|
|
GHRL
|
ghrelin/obestatin prepropeptide
|
|
GJA1
|
gap junction protein, alpha 1, 43kDa
|
|
GJB2
|
gap junction protein, beta 2, 26kDa
|
|
GNA13
|
guanine nucleotide binding protein (G protein), alpha 13
|
|
GP1BA
|
glycoprotein Ib (platelet), alpha polypeptide
|
|
GRM3
|
glutamate receptor, metabotropic 3
|
|
GSK3B
|
glycogen synthase kinase 3 beta
|
|
HAMP
|
hepcidin antimicrobial peptide
|
|
HBB
|
hemoglobin, beta
|
|
HDAC6
|
histone deacetylase 6
|
|
HGF
|
hepatocyte growth factor (hepapoietin A; scatter factor)
|
|
HLA-A
|
major histocompatibility complex, class I, A
|
|
HNRNPA1
|
heterogeneous nuclear ribonucleoprotein A1
|
|
HRAS
|
Harvey rat sarcoma viral oncogene homolog
|
|
HSPA4
|
heat shock 70kDa protein 4
|
|
HSPA8
|
heat shock 70kDa protein 8
|
|
HTR2C
|
5-hydroxytryptamine (serotonin) receptor 2C, G protein-coupled
|
|
HTT
|
huntingtin
|
|
IFITM2
|
interferon induced transmembrane protein 2
|
|
IFITM3
|
interferon induced transmembrane protein 3
|
|
IFNG
|
interferon, gamma
|
|
IGF1R
|
insulin-like growth factor 1 receptor
|
|
IGF2
|
insulin-like growth factor 2
|
|
IKBKE
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase epsilon
|
|
IKBKG
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma
|
|
IL6
|
interleukin 6
|
|
IMMP2L
|
IMP2 inner mitochondrial membrane peptidase-like (S. cerevisiae)
|
|
INHA
|
inhibin, alpha
|
|
IP6K1
|
inositol hexakisphosphate kinase 1
|
|
IRAK1
|
interleukin-1 receptor-associated kinase 1
|
|
IRAK4
|
interleukin-1 receptor-associated kinase 4
|
|
ITGA3
|
integrin, alpha 3 (antigen CD49C, alpha 3 subunit of VLA-3 receptor)
|
|
KAT8
|
K(lysine) acetyltransferase 8
|
|
KCNV2
|
potassium channel, voltage gated modifier subfamily V, member 2
|
|
KIAA2022
|
KIAA2022
|
|
KLF11
|
Kruppel-like factor 11
|
|
KMT2A
|
lysine (K)-specific methyltransferase 2A
|
|
KRAS
|
Kirsten rat sarcoma viral oncogene homolog
|
|
KRT10
|
keratin 10, type I
|
|
LCP2
|
lymphocyte cytosolic protein 2 (SH2 domain containing leukocyte protein of 76kDa)
|
|
LRRK2
|
leucine-rich repeat kinase 2
|
|
LZTS3
|
leucine zipper, putative tumor suppressor family member 3
|
|
MAP3K7
|
mitogen-activated protein kinase kinase kinase 7
|
|
MAPRE3
|
microtubule-associated protein, RP/EB family, member 3
|
|
MCPH1
|
microcephalin 1
|
|
MDC1
|
mediator of DNA-damage checkpoint 1
|
|
MECP2
|
methyl CpG binding protein 2
|
|
MEF2C
|
myocyte enhancer factor 2C
|
|
MESDC2
|
mesoderm development candidate 2
|
|
MET
|
MET proto-oncogene, receptor tyrosine kinase
|
|
MLH1
|
mutL homolog 1
|
|
MLLT3
|
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 3
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MSTN
|
myostatin
|
|
MTM1
|
myotubularin 1
|
|
NBAS
|
neuroblastoma amplified sequence
|
|
NBEA
|
neurobeachin
|
|
NCF1C
|
neutrophil cytosolic factor 1C pseudogene
|
|
NCF2
|
neutrophil cytosolic factor 2
|
|
NCR1
|
natural cytotoxicity triggering receptor 1
|
|
NCR2
|
natural cytotoxicity triggering receptor 2
|
|
NCSTN
|
nicastrin
|
|
NDE1
|
nudE neurodevelopment protein 1
|
|
NDEL1
|
nudE neurodevelopment protein 1-like 1
|
|
NFE2L2
|
nuclear factor, erythroid 2-like 2
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
|
NLGN4X
|
neuroligin 4, X-linked
|
|
NPHS1
|
nephrosis 1, congenital, Finnish type (nephrin)
|
|
NR2F2
|
nuclear receptor subfamily 2, group F, member 2
|
|
NR4A2
|
nuclear receptor subfamily 4, group A, member 2
|
|
NRXN1
|
neurexin 1
|
|
NTNG1
|
netrin G1
|
|
ORAI1
|
ORAI calcium release-activated calcium modulator 1
|
|
ORAI3
|
ORAI calcium release-activated calcium modulator 3
|
|
PAH
|
phenylalanine hydroxylase
|
|
PARK2
|
parkin RBR E3 ubiquitin protein ligase
|
|
PARK7
|
parkinson protein 7
|
|
PAX5
|
paired box 5
|
|
PDGFB
|
platelet-derived growth factor beta polypeptide
|
|
PER1
|
period circadian clock 1
|
|
PEX13
|
peroxisomal biogenesis factor 13
|
|
PFDN2
|
prefoldin subunit 2
|
|
PFDN5
|
prefoldin subunit 5
|
|
PGGT1B
|
protein geranylgeranyltransferase type I, beta subunit
|
|
PGR
|
progesterone receptor
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
|
PIK3R1
|
phosphoinositide-3-kinase, regulatory subunit 1 (alpha)
|
|
PKD1
|
polycystic kidney disease 1 (autosomal dominant)
|
|
PLAUR
|
plasminogen activator, urokinase receptor
|
|
PLK4
|
polo-like kinase 4
|
|
PMAIP1
|
phorbol-12-myristate-13-acetate-induced protein 1
|
|
POU2F3
|
POU class 2 homeobox 3
|
|
PPARG
|
peroxisome proliferator-activated receptor gamma
|
|
PPP2CA
|
protein phosphatase 2, catalytic subunit, alpha isozyme
|
|
PRDM1
|
PR domain containing 1, with ZNF domain
|
|
PRKCE
|
protein kinase C, epsilon
|
|
PRL
|
prolactin
|
|
PRSS1
|
protease, serine, 1 (trypsin 1)
|
|
PTEN
|
phosphatase and tensin homolog
|
|
PTPN11
|
protein tyrosine phosphatase, non-receptor type 11
|
|
PTPRD
|
protein tyrosine phosphatase, receptor type, D
|
|
PTTG1
|
pituitary tumor-transforming 1
|
|
RAC1
|
ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1)
|
|
RAN
|
RAN, member RAS oncogene family
|
|
RDH5
|
retinol dehydrogenase 5 (11-cis/9-cis)
|
|
RDX
|
radixin
|
|
RELA
|
v-rel avian reticuloendotheliosis viral oncogene homolog A
|
|
REST
|
RE1-silencing transcription factor
|
|
RET
|
ret proto-oncogene
|
|
RHOA
|
ras homolog family member A
|
|
RHOB
|
ras homolog family member B
|
|
RIOK2
|
RIO kinase 2
|
|
RIPK1
|
receptor (TNFRSF)-interacting serine-threonine kinase 1
|
|
RPL11
|
ribosomal protein L11
|
|
RPL5
|
ribosomal protein L5
|
|
RSAD2
|
radical S-adenosyl methionine domain containing 2
|
|
RSPO1
|
R-spondin 1
|
|
RUNX2
|
runt-related transcription factor 2
|
|
S100B
|
S100 calcium binding protein B
|
|
SAMHD1
|
SAM domain and HD domain 1
|
|
SCN4A
|
sodium channel, voltage gated, type IV alpha subunit
|
|
SCN5A
|
sodium channel, voltage gated, type V alpha subunit
|
|
SEMA3A
|
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3A
|
|
SENP1
|
SUMO1/sentrin specific peptidase 1
|
|
SH3PXD2A
|
SH3 and PX domains 2A
|
|
SHH
|
sonic hedgehog
|
|
SIRPA
|
signal-regulatory protein alpha
|
|
SLC12A5
|
solute carrier family 12 (potassium/chloride transporter), member 5
|
|
SLC3A2
|
solute carrier family 3 (amino acid transporter heavy chain), member 2
|
|
SLC4A10
|
solute carrier family 4, sodium bicarbonate transporter, member 10
|
|
SLC7A7
|
solute carrier family 7 (amino acid transporter light chain, y+L system), member 7
|
|
SMARCA5
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 5
|
|
SMO
|
smoothened, frizzled class receptor
|
|
SNX3
|
sorting nexin 3
|
|
SOST
|
sclerostin
|
|
SOX9
|
SRY (sex determining region Y)-box 9
|
|
SP1
|
Sp1 transcription factor
|
|
SPI1
|
Spi-1 proto-oncogene
|
|
SPIN1
|
spindlin 1
|
|
SPINK1
|
serine peptidase inhibitor, Kazal type 1
|
|
SQSTM1
|
sequestosome 1
|
|
STAT1
|
signal transducer and activator of transcription 1, 91kDa
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
STAT5A
|
signal transducer and activator of transcription 5A
|
|
STAT5B
|
signal transducer and activator of transcription 5B
|
|
STAT6
|
signal transducer and activator of transcription 6, interleukin-4 induced
|
|
STX16
|
syntaxin 16
|
|
STX6
|
syntaxin 6
|
|
TAAR6
|
trace amine associated receptor 6
|
|
TAF4
|
TAF4 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 135kDa
|
|
TAF7
|
TAF7 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 55kDa
|
|
TARDBP
|
TAR DNA binding protein
|
|
TCF7L2
|
transcription factor 7-like 2 (T-cell specific, HMG-box)
|
|
TEAD1
|
TEA domain family member 1 (SV40 transcriptional enhancer factor)
|
|
TENM4
|
teneurin transmembrane protein 4
|
|
TGFA
|
transforming growth factor, alpha
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
TGFBR3
|
transforming growth factor, beta receptor III
|
|
TJP1
|
tight junction protein 1
|
|
TLR2
|
toll-like receptor 2
|
|
TLR3
|
toll-like receptor 3
|
|
TLR4
|
toll-like receptor 4
|
|
TNFAIP3
|
tumor necrosis factor, alpha-induced protein 3
|
|
TNFRSF1A
|
tumor necrosis factor receptor superfamily, member 1A
|
|
TP53
|
tumor protein p53
|
|
TRADD
|
TNFRSF1A-associated via death domain
|
|
TRAF6
|
TNF receptor-associated factor 6, E3 ubiquitin protein ligase
|
|
TRPC6
|
transient receptor potential cation channel, subfamily C, member 6
|
|
TSC2
|
tuberous sclerosis 2
|
|
TUBA4A
|
tubulin, alpha 4a
|
|
UBR4
|
ubiquitin protein ligase E3 component n-recognin 4
|
|
VAMP4
|
vesicle-associated membrane protein 4
|
|
VIM
|
vimentin
|
|
VTI1A
|
vesicle transport through interaction with t-SNAREs 1A
|
|
WEE1
|
WEE1 G2 checkpoint kinase
|
|
XRCC3
|
X-ray repair complementing defective repair in Chinese hamster cells 3
|
|
YAP1
|
Yes-associated protein 1
|
|
ZCCHC7
|
zinc finger, CCHC domain containing 7
|
